Search

Lexicon Pharmaceuticals Inc

Ouvert

SecteurSoins de santé

1.87

Résumé

Variation du prix de l'action

24h

Actuel

Min

1.8399999999999999

Max

1.94

Chiffres clés

By Trading Economics

Revenu

-32M

-33M

Ventes

-20M

692K

BPA

-0.06

Marge bénéficiaire

-4,742.486

Employés

81

EBITDA

-30M

-29M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+207.18% upside

Dividendes

By Acuity

Prochains Résultats

5 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-190M

845M

Ouverture précédente

1.87

Clôture précédente

1.87

Sentiment de l'Actualité

By Acuity

16%

84%

13 / 339 Classement par Healthcare

Lexicon Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

29 sept. 2026, 22:31 UTC

Lexicon Pharmaceuticals Inc has advanced significantly in after-market trading, now about 4% below its 20-day moving average following Tuesday's close.

28 sept. 2026, 22:01 UTC

News

Lexicon Pharmaceuticals Inc is up in after-market trading after Cantor Fitzgerald initiated coverage with an "overweight" rating and an $8 price target.

25 sept. 2026, 23:55 UTC

Lexicon Pharmaceuticals Inc is rising in after-market trading, gaining ground since Friday's close, marking a notable divergence from four consecutive sessions of losses.

24 sept. 2026, 20:01 UTC

Lexicon Pharmaceuticals Inc shares fell sharply, reversing a trend of higher daily closes amid a broader market context of diverging momentum.

23 sept. 2026, 20:07 UTC

Lexicon Pharmaceuticals Inc shares fell sharply, finishing significantly lower on Wednesday, hitting a low around midday before a slight late-session recovery.

22 sept. 2026, 20:01 UTC

Lexicon Pharmaceuticals Inc is gaining strength during Tuesday's session, reaching a peak earlier before pulling back slightly while remaining below its 20-day moving average.

21 sept. 2026, 20:40 UTC

Lexicon Pharmaceuticals Inc is declining in after-market trading, influenced by a drop in the Chicago Fed National Activity Index and broader market trends.

16 sept. 2026, 20:10 UTC

Macro Event

Lexicon Pharmaceuticals Inc is advancing, continuing a modest upward trend since Tuesday, amid sensitivity to macroeconomic developments following the Fed's interest rate hike.

11 sept. 2026, 20:08 UTC

Lexicon Pharmaceuticals Inc. shares are lower today, continuing a decline since Thursday's close. Earlier, the stock peaked before reversing course during routine fluctuations.

10 sept. 2026, 19:21 UTC

News

Lexicon Pharmaceuticals is lower today, continuing a five-session decline amid broader market pressures following the European Central Bank's interest rate hike.

8 sept. 2026, 20:07 UTC

Lexicon Pharmaceuticals shares are lower today, following a strong jobs report that raised interest rate hike speculation. The stock remains below its 20-day moving average.

5 sept. 2026, 00:00 UTC

Lexicon Pharmaceuticals Inc shares are higher in after-market trading, reflecting gains since Friday's close amid broader market dynamics and strong labor market data.

3 sept. 2026, 19:26 UTC

Lexicon Pharmaceuticals Inc is higher today, with no specific news identified. Broader market declines in Treasury yields may be influencing trading.

24 août 2026, 19:36 UTC

News

Lexicon Pharmaceuticals received a $10 million milestone payment from Novo Nordisk, bringing total payments to $75 million as shares rise during Monday's session.

21 août 2026, 19:36 UTC

Lexicon Pharmaceuticals Inc shares are higher in Friday's session, continuing an upward trend since Thursday. The stock remains below its 20-day moving average.

20 août 2026, 23:56 UTC

Lexicon Pharmaceuticals Inc shares are rising in after-market trading, showing positive momentum despite being below their 20-day moving average. No specific news was identified.

18 août 2026, 19:31 UTC

Lexicon Pharmaceuticals Inc shares are higher today, driven by significant gains in the Biotechnology sub-sector. The stock is near its one-month high.

13 août 2026, 19:56 UTC

Lexicon Pharmaceuticals is trading lower today amid no specific news. First-time claims for U.S. unemployment benefits rose, but investor sentiment remains stable.

12 août 2026, 23:36 UTC

Lexicon Pharmaceuticals Inc's shares are higher in after-market trading, with no specific news identified. Broader market sentiment may be influenced by recent inflation data.

11 août 2026, 23:26 UTC

Lexicon Pharmaceuticals Inc. shares are lower in after-market trading, with no specific news identified. Broader market sentiment remains cautious amid oil price developments.

10 août 2026, 19:56 UTC

News

Lexicon Pharmaceuticals reported a second-quarter earnings loss of -$0.06 per share, missing expectations. Shares are lower amid a downgrade to “sell” from Wall Street Zen.

7 août 2026, 22:01 UTC

Lexicon Pharmaceuticals Inc shares are lower in after-market hours, continuing a notable decline since Friday's close, with no specific news identified to explain the movement.

6 août 2026, 23:26 UTC

Lexicon Pharmaceuticals shares are trading higher in after-market hours, following three consecutive sessions of declines. No specific news was identified for the price movement.

5 août 2026, 19:36 UTC

News

Lexicon Pharmaceuticals Inc shares are lower as investors adjust positions ahead of Q2 earnings on August 5, with consensus EPS estimates at -$0.05.

4 août 2026, 19:56 UTC

Lexicon Pharmaceuticals shares are higher today, reflecting strong momentum amid easing inflation concerns from declining crude oil prices. No specific news was identified.

31 juil. 2026, 19:46 UTC

Lexicon Pharmaceuticals Inc shares are lower today, reflecting broader market trends amid rising yields and crude oil prices contributing to inflation concerns.

30 juil. 2026, 23:11 UTC

Lexicon Pharmaceuticals Inc shares are lower in after-market hours. The decline follows broader market uncertainty after the Federal Reserve's interest rate decision.

29 juil. 2026, 21:02 UTC

Lexicon Pharmaceuticals Inc shares are lower in after-market trading, reflecting broader market declines amid rising oil prices and geopolitical tensions in the Middle East.

27 juil. 2026, 19:03 UTC

Lexicon Pharmaceuticals Inc is trading lower today, breaking a trend of higher daily closes. Broader market declines and falling oil prices may influence sentiment.

24 juil. 2026, 20:07 UTC

Lexicon Pharmaceuticals Inc shares are lower today, reversing from earlier gains amid broader market volatility influenced by falling oil prices and inflation concerns.

Comparaison

Variation de prix

Lexicon Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

207.18% hausse

Prévisions sur 12 Mois

Moyen 5.775 USD  207.18%

Haut 8 USD

Bas 3.1 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

4 ratings

4

Achat

0

Maintien

0

Vente

Sentiment

By Acuity

13 / 339Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.